Table 3. Main imaging cardiac features of 157 cardiac sarcoidosis patients, according to the presence of cardiac relapse.
| Variables | Total | Cardiac relapse | No cardiac relapse |
|---|---|---|---|
| Total number of patients | 157 | 63 | 94 |
| ECHOCARDIOGRAPHY, (n = 157), number (%) | |||
| Any abnormality | 98 (62) | 48 (76) | 50 (53) |
| Diffuse hypokinesia | 41 (26) | 23 (37) | 18 (19) |
| Localized hypokinesia | 40 (25) | 20 (32) | 20 (21) |
| Wall motion abnormalities | 20 (13) | 13 (21) | 7 (7) |
| Thick interventricular septum | 18 (12) | 6 (10) | 12 (13) |
| Abnormal pericardium | 18 (11) | 6 (10) | 12 (13) |
| Left ventricular ejection fraction | |||
| > 50% | 112 (74) | 41 (69) | 71 (76) |
| 50–40% | 25 (16) | 10 (17) | 15 (16) |
| < 40% | 15 (10) | 8 (14) | 7 (8) |
| CARDIAC SCINTIGRAPHY (n = 133), number (%) | |||
| Localized perfusion defects | 98 (74) | 40 (73) | 58 (74) |
| Diffuse perfusion defects | 9 (7) | 5 (9) | 4 (5) |
| CARDIAC MRI (n = 91), number (%) | |||
| Any abnormality | 68 (75) | 28 (85) | 40 (69) |
| Hypersignals (T1 mapping)* | 24 (28) | 11 (34) | 13 (24) |
| Early gadolinium enhancement † | 12 (14) | 6 (18) | 6 (11) |
| Delayed gadolinium enhancement † | 39 (44) | 19 (58) | 20 (36) |
| Localized hypokinesia† | 7 (8) | 3 (9) | 4 (7) |
| Low left ventricular ejection fraction† | 28 (32) | 11 (33) | 17 (31) |
| Abnormal pericardium** | 9 (11) | 1 (3) | 8 (15) |
| CARDIAC PET SCAN (n = 37), number (%) | |||
| Patchy uptake | 12 (32) | 2 (13) | 10 (45) |
MRI, magnetic resonance imaging; PET scan, positron emission tomography.
*n = 87
†: n = 88
**n = 85